Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects

2017 ◽  
Vol 20 (4) ◽  
pp. 107-107
Author(s):  
Annette Regan
Author(s):  
Mohinder Sarna ◽  
Gavin Pereira ◽  
Damien Foo ◽  
Annette Regan

Objective: Seasonal inactivated influenza vaccine (IIV) is recommended during pregnancy to protect both mothers and infants from severe infection. Most studies have evaluated the risk of major structural birth defects in infants associated with prenatal administration of pandemic IIV. Our aim was to estimate the risk in infants associated with prenatal administration of seasonal IIV. Design: Retrospective population-based observational study Setting: Western Australia Population or sample: All pregnant women with a singleton birth from 2012-2016 Methods: 125,866 singleton births were linked to the state’s registers for congenital anomalies and a state prenatal vaccination database. We estimated prevalence ratios (PR) of any major structural birth defect and defects by organ system. Inverse probability treatment weighting factored for baseline probability for vaccination. Bonferroni correction was applied to account for multiple comparisons. Main outcome measures: Prevalence ratios by vaccination and major structural birth defects categories or specific birth defects diagnosed within one month of birth or within six years of life. Results: 3.9% of births had a major structural birth defect. IIV exposure during the first trimester was not associated with diagnosis of any major structural birth defect diagnosed within one month of birth (PR 0.98, 95% CI: 0.77, 1.28) or within six years of life (PR 1.02, 95% CI: 0.78, 1.35). We identified no increased risk in specific birth defects associated with IIV. Conclusions: Results suggest there is no association between maternal influenza vaccination and risk of major structural birth defects. These results support the safety of IIV administration during pregnancy.


2017 ◽  
Vol 187 ◽  
pp. 234-239.e4 ◽  
Author(s):  
Elyse Olshen Kharbanda ◽  
Gabriela Vazquez-Benitez ◽  
Paul A. Romitti ◽  
Allison L. Naleway ◽  
T. Craig Cheetham ◽  
...  

2020 ◽  
Vol 77 (3) ◽  
pp. 172-178 ◽  
Author(s):  
Nynke Spinder ◽  
Lynn M Almli ◽  
Tania A Desrosiers ◽  
Kathryn E Arnold ◽  
Jorieke E H Bergman ◽  
...  

ObjectivesThe aim of this study was to assess the association between maternal occupational exposure to solvents and gastroschisis in offspring.MethodsWe used data from the National Birth Defects Prevention Study, a large population-based case-control study of major birth defects conducted in 10 US states from 1997 to 2011. Infants with gastroschisis were ascertained by active birth defects surveillance systems. Control infants without major birth defects were selected from vital records or birth hospital records. Self-reported maternal occupational histories were collected by telephone interview. Industrial hygienists reviewed this information to estimate exposure to aromatic, chlorinated and petroleum-based solvents from 1 month before conception through the first trimester of pregnancy. Cumulative exposure to solvents was estimated for the same period accounting for estimated exposure intensity and frequency, job duration and hours worked per week. ORs and 95% CIs were estimated to assess the association between exposure to any solvents or solvent classes, and gastroschisis risk.ResultsAmong 879 cases and 7817 controls, the overall prevalence of periconceptional solvent exposure was 7.3% and 7.4%, respectively. Exposure to any solvent versus no exposure to solvents was not associated with gastroschisis after adjusting for maternal age (OR 1.00, 95% CI 0.75 to 1.32), nor was an association noted for solvent classes. There was no exposure-response relationship between estimated cumulative solvent exposure and gastroschisis after adjusting for maternal age.ConclusionOur study found no association between maternal occupational solvent exposure and gastroschisis in offspring. Further research is needed to understand risk factors for gastroschisis.


2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Alexander A. Leung ◽  
Jennifer Yamamoto ◽  
Paola Luca ◽  
Paul Beaudry ◽  
Julie McKeen

Exposure to propylthiouracil in early pregnancy may be associated with an increased risk of birth defects. But the spectrum of associated congenital anomalies is not yet well defined. While preliminary reports suggest that most cases of propylthiouracil-associated birth defects are restricted to the preauricular and urinary systems, careful consideration should be given to other possible manifestations of teratogenicity. We propose that congenital bands may potentially represent a rare yet serious complication of propylthiouracil exposure in early pregnancy, possibly arising from an early mesenteric developmental anomaly. We report a case of a 17-day-old girl that presented with acute small bowel obstruction associated with intestinal malrotation arising from several anomalous congenital bands. Her mother was treated for Graves’ disease during pregnancy with first trimester exposure to propylthiouracil but remained clinically and biochemically euthyroid at conception and throughout the duration of pregnancy. This case suggests that the use of propylthiouracil in early pregnancy may be associated with congenital bands and intestinal malrotation. More reports are needed to further support this association.


2014 ◽  
Vol 20 (5) ◽  
pp. 656-669 ◽  
Author(s):  
Matteo Cassina ◽  
Marta Donà ◽  
Elena Di Gianantonio ◽  
Pietro Litta ◽  
Maurizio Clementi

2009 ◽  
Vol 201 (6) ◽  
pp. S232 ◽  
Author(s):  
Jeanne S. Sheffield ◽  
Laura Greer ◽  
Tamara Chao ◽  
Vanessa Rogers ◽  
Scott Roberts ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document